Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Food Allergenic Extract [EPC]
Rye (Secale cereale) extracts are pharmacological agents classified as non-standardized food and plant allergenic extracts, primarily utilized for the diagnosis and treatment of IgE-mediated allergic sensitivities through skin testing and subcutaneous immunotherapy.
Name
Rye
Raw Name
RYE
Category
Non-Standardized Food Allergenic Extract [EPC]
Drug Count
10
Variant Count
10
Last Verified
February 17, 2026
About Rye
Rye (Secale cereale) extracts are pharmacological agents classified as non-standardized food and plant allergenic extracts, primarily utilized for the diagnosis and treatment of IgE-mediated allergic sensitivities through skin testing and subcutaneous immunotherapy.
Detailed information about Rye
References used for this content
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Rye.
Rye, scientifically known as Secale cereale, is utilized in clinical medicine as a non-standardized allergenic extract. It belongs to a broad pharmacological class known as Non-Standardized Plant Allergenic Extracts [EPC] and Non-Standardized Food Allergenic Extracts [EPC]. These preparations are biological products derived from the pollen or grain of the rye plant, a member of the Poaceae (grass) family. In the United States, these extracts are regulated by the FDA's Center for Biologics Evaluation and Research (CBER). Rye allergenic extracts are primarily indicated for two clinical purposes: the diagnostic identification of specific allergic sensitivities (via skin prick or intradermal testing) and the therapeutic desensitization of patients with allergic rhinitis, allergic conjunctivitis, or allergic asthma through a process known as allergen immunotherapy (AIT).
As a non-standardized extract, the potency of Rye is not measured in Bioequivalent Allergy Units (BAU) but is typically expressed in terms of weight/volume (w/v) or Protein Nitrogen Units (PNU). This classification distinguishes it from standardized extracts like certain Timothy grass or Ragweed preparations, which have federally mandated potency requirements. Healthcare providers utilize Rye extracts to help patients manage 'hay fever' or seasonal allergies that occur when rye pollen is prevalent in the atmosphere, as well as food-based sensitivities to the grain itself.
The mechanism of action for Rye allergenic extracts depends on the mode of administration and the clinical objective. When used for diagnostic skin testing, the extract acts as an antigen that cross-links specific Immunoglobulin E (IgE) antibodies bound to the surface of mast cells and basophils in the skin. This cross-linking triggers degranulation, releasing histamine, leukotrienes, and other inflammatory mediators. This physiological cascade results in a 'wheal and flare' reaction (a raised bump surrounded by redness), which serves as a visible indicator of the patient's sensitivity to Rye allergens.
When used therapeutically in subcutaneous immunotherapy (SCIT), the mechanism is more complex and involves the induction of immunological tolerance. Repeated, escalating exposure to Rye allergens shifts the immune response from a Th2-dominated profile (associated with allergy) to a Th1-dominated profile. This process stimulates the production of 'blocking antibodies,' specifically IgG4, which compete with IgE for allergen binding sites. Furthermore, it induces the expansion of regulatory T-cells (Tregs) that secrete anti-inflammatory cytokines like Interleukin-10 (IL-10) and Transforming Growth Factor-beta (TGF-β), effectively suppressing the allergic cascade upon future natural exposure to rye pollen or grain.
Unlike traditional small-molecule drugs, allergenic extracts like Rye do not follow standard pharmacokinetic models involving absorption, distribution, metabolism, and excretion (ADME) through the cytochrome P450 system.
Rye allergenic extracts are FDA-approved for the following indications:
Rye extracts are available in several concentrated forms, typically packaged in multidial vials:
> Important: Only your healthcare provider (typically an allergist or immunologist) can determine if Rye allergenic extract is appropriate for your specific diagnostic or therapeutic needs. Proper administration is critical to ensure safety and efficacy.
Dosage for Rye allergenic extracts is highly individualized and must be determined by a specialist based on the patient's sensitivity level.
For skin prick testing, a single drop of a 1:10 or 1:20 w/v concentration is typically applied to the skin, followed by a puncture. For intradermal testing, 0.02 to 0.05 mL of a much more dilute solution (e.g., 1:1000 or 1:10,000 w/v) is injected into the dermis.
Therapeutic dosing follows a two-phase schedule:
Rye allergenic extracts are generally considered safe for use in children, typically starting around age 5. Dosing principles are similar to adults, but the physician may choose a more conservative build-up schedule. There is no established safety data for children under the age of 2, as their immune systems are still developing, and the risk-to-benefit ratio is often unfavorable.
No specific dosage adjustments are required for patients with renal impairment, as the extract is not cleared through traditional renal pathways in a way that affects toxicity. However, if a systemic reaction occurs, the patient's ability to handle emergency medications (like epinephrine) must be considered.
No dosage adjustments are necessary for patients with liver disease.
Elderly patients (over 65) require careful assessment of their cardiovascular status. If an older patient has significant heart disease, they may be at higher risk if a systemic reaction occurs, and their response to epinephrine may be compromised.
Rye allergenic extracts for immunotherapy are administered via subcutaneous injection only. They should never be injected intravenously.
If a dose in the build-up phase is missed, the next dose may need to be reduced to ensure safety.
An 'overdose' in the context of Rye extract usually refers to an injection of a concentration higher than the patient's current tolerance level.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not attempt to self-administer these injections unless specifically trained and authorized by your physician in an exceptionally rare home-use protocol.
Local reactions are the most frequent side effects associated with Rye allergenic extracts. These occur at the site of the injection and are generally considered a normal part of the immune system's response to the antigen.
These reactions are systemic but usually mild to moderate in severity:
> Warning: Stop taking Rye and call your doctor immediately or seek emergency care if you experience any of the following signs of a systemic allergic reaction:
There are no known long-term 'toxic' effects of Rye allergenic extracts on organs like the liver or kidneys. The primary long-term consideration is the potential for the patient to develop new sensitivities, though immunotherapy is generally thought to prevent the 'allergic march' (the development of additional allergies). In rare cases, chronic local reactions can lead to minor skin changes at the site of repeated injections.
While Rye extracts may not always carry a specific 'Black Box' on every individual manufacturer's label, the entire class of allergenic extracts is subject to stringent FDA safety requirements. The primary warning states that these products can cause severe life-threatening systemic reactions, including anaphylaxis. They must only be administered by healthcare providers prepared to manage such reactions and in facilities equipped with emergency supplies (epinephrine, oxygen, airway management tools). Patients with unstable asthma are at significantly higher risk for fatal outcomes.
Report any unusual symptoms or reactions that occur even hours after your injection to your healthcare provider.
Rye allergenic extracts are biological products that carry an inherent risk of triggering the very allergic symptoms they are intended to treat. Safety is paramount, and the following precautions must be strictly observed. Patients must be in their baseline state of health before receiving an injection. If you are feeling ill, have a fever, or are experiencing an asthma flare-up, the injection must be postponed.
No routine lab tests (like blood counts or liver enzymes) are required for Rye immunotherapy. However, clinical monitoring is intensive:
While Rye itself does not cause sedation, a systemic reaction or the administration of emergency antihistamines/epinephrine can significantly impair your ability to drive. It is recommended that patients avoid strenuous exercise for several hours after an injection, as increased blood flow can accelerate the absorption of the allergen.
Alcohol consumption should be avoided on the day of an injection. Alcohol causes vasodilation (widening of blood vessels), which could theoretically increase the speed of allergen absorption and increase the risk of a systemic reaction.
There is no 'withdrawal syndrome' associated with stopping Rye extracts. However, stopping immunotherapy prematurely (before 3 years) often results in the return of allergy symptoms. If treatment is paused for a significant period, it cannot be resumed at the previous dose; a 'step-back' in concentration is required to ensure safety.
> Important: Discuss all your medical conditions, especially respiratory or heart problems, with your healthcare provider before starting Rye extracts.
There are few absolute contraindications for drug combinations, but the following are generally avoided due to extreme safety risks:
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially those for blood pressure, heart rhythm, or depression.
Rye allergenic extracts must NEVER be used in the following circumstances:
Conditions requiring a careful risk-benefit analysis include:
Patients allergic to Rye (Secale cereale) often show cross-reactivity with other members of the Poaceae family, including:
This cross-sensitivity occurs because these plants share homologous (similar) proteins. A patient highly sensitive to one may react to another, which must be considered when formulating a multi-allergen extract vial.
> Important: Your healthcare provider will evaluate your complete medical history, including your respiratory and cardiovascular health, before prescribing Rye.
Rye allergenic extracts are classified as Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women.
It is not known whether Rye allergen components are excreted in human milk. However, because these are large proteins and the amount administered is minute, it is highly unlikely that they would be absorbed intact from the infant's gastrointestinal tract. Most experts consider immunotherapy compatible with breastfeeding.
As Rye allergens are biological proteins degraded by proteases, renal impairment does not lead to drug accumulation. No dose adjustments are required for patients with chronic kidney disease (CKD), though their overall health stability should be assessed.
Liver disease does not affect the safety or efficacy of Rye allergenic extracts. No dose adjustments are necessary for patients with any degree of hepatic impairment.
> Important: Special populations require individualized medical assessment. Always inform your allergist if you become pregnant or develop new health conditions during treatment.
Rye allergenic extract functions as an immunomodulator. In the diagnostic phase, it acts as an elicitor of a Type I hypersensitivity reaction by binding to IgE on mast cells. In the therapeutic phase, it induces a state of desensitization. This is achieved by shifting the T-cell response from Th2 (which produces IL-4, IL-5, and IL-13) to Th1 (which produces IFN-gamma). Furthermore, it promotes the production of IL-10 by regulatory T-cells, which inhibits mast cell activation and promotes the production of IgG4 'blocking' antibodies. These IgG4 antibodies prevent the allergen from reaching the IgE on mast cells, thereby stopping the allergic reaction before it starts.
| Parameter | Value |
|---|---|
| Bioavailability | N/A (Subcutaneous injection) |
| Protein Binding | N/A (Interacts with IgE/IgG) |
| Half-life | N/A (Biological degradation) |
| Tmax | 15-30 minutes (systemic absorption) |
| Metabolism | Local and systemic proteolysis |
| Excretion | Renal (as peptide fragments) |
Rye is classified as a Non-Standardized Allergenic Extract. It belongs to the therapeutic class of 'Allergenics' and the functional class of 'Immunotherapy Agents.' It is related to other grass extracts such as Orchard Grass, Kentucky Bluegrass, and Redtop Grass.
Common questions about Rye
In a clinical setting, Rye refers to an allergenic extract used for the diagnosis and treatment of allergies. It is used in skin prick tests to confirm if a patient is allergic to rye pollen or grain. If an allergy is confirmed, the extract can be used in 'allergy shots' (immunotherapy) to gradually desensitize the patient's immune system. This helps reduce symptoms like sneezing, itchy eyes, and asthma caused by rye exposure. It is not used as a medication to treat the symptoms directly, but rather to modify the underlying immune response.
The most common side effects are local reactions at the site of the injection, occurring in a majority of patients. These include redness, swelling, itching, and a mild aching sensation in the arm. These reactions usually appear within minutes and resolve within 24 to 48 hours. Some patients may also experience mild systemic symptoms like sneezing or a runny nose shortly after the injection. While bothersome, these common side effects are typically not dangerous and can be managed with over-the-counter antihistamines or cold compresses.
It is generally advised to avoid alcohol consumption on the day you receive a Rye allergenic injection. Alcohol can cause your blood vessels to dilate (expand), which may speed up the absorption of the allergen into your bloodstream. This increased absorption rate can raise the risk of a systemic allergic reaction or anaphylaxis. Furthermore, alcohol can mask the early symptoms of a reaction, making it harder for you or your doctor to identify a problem. Always wait at least 24 hours after your injection before consuming alcohol.
Rye allergenic extracts are generally not started during pregnancy because of the risk of a severe allergic reaction, which could harm the fetus by reducing oxygen supply. However, if a woman is already on a stable maintenance dose of Rye immunotherapy before becoming pregnant, most allergists will continue the treatment. The dose is usually not increased during pregnancy to minimize the risk of a reaction. If you are planning to become pregnant or find out you are pregnant while on Rye therapy, you must inform your allergist immediately to discuss a safety plan.
Immunotherapy with Rye is a long-term commitment and does not provide immediate relief. Most patients begin to notice a reduction in their allergy symptoms during the first 'maintenance' season, which is usually 3 to 6 months after starting the injections. Significant improvement is typically seen after one full year of treatment. For the best long-term results and to potentially achieve permanent remission of allergies, a full course of treatment lasting 3 to 5 years is generally recommended by clinical guidelines.
Yes, you can stop Rye immunotherapy injections suddenly without experiencing withdrawal symptoms, as it is not an addictive medication. However, stopping the treatment before the recommended 3-to-5-year mark often leads to the return of allergy symptoms over time. If you stop for several weeks and then decide to restart, you cannot simply take your last dose; your doctor will need to significantly reduce the dose to ensure your safety. Always consult your allergist before deciding to discontinue your immunotherapy program.
If you miss a scheduled Rye injection, contact your allergist's office to reschedule as soon as possible. The protocol for a missed dose depends on how long it has been since your last injection. If it has only been an extra week, you may be able to continue as planned. If several weeks have passed, your doctor will likely need to reduce your next dose to prevent a reaction. Never try to 'double up' on doses to make up for a missed one, as this significantly increases the risk of anaphylaxis.
There is no clinical evidence to suggest that Rye allergenic extracts cause weight gain. Unlike systemic corticosteroids (like prednisone), which are known to cause weight changes and metabolic issues, allergenic extracts are biological proteins that work locally on the immune system. They do not affect your metabolism, appetite, or fat distribution. If you experience weight gain while on immunotherapy, it is likely due to other factors or medications, and you should discuss this with your primary care physician.
Rye can be taken alongside most common medications, but there are critical exceptions. You must inform your doctor if you are taking beta-blockers, ACE inhibitors, or MAO inhibitors, as these can make allergic reactions more dangerous or harder to treat. Additionally, antihistamines must be stopped several days before diagnostic skin testing with Rye, as they will hide the results. Most other medications for chronic conditions like cholesterol or diabetes do not interact with Rye extracts, but a full medication review is necessary.
The concept of 'generic' vs. 'brand name' is different for allergenic extracts than for pills. Rye extracts are biological products produced by several different laboratories (such as ALK, Greer, or HollisterStier). While they all contain the same active *Secale cereale* proteins, they are 'non-standardized,' meaning the exact potency can vary slightly between manufacturers. Therefore, they are not considered interchangeable generics. Your allergist will typically stick with one manufacturer for your entire course of treatment to ensure consistent dosing and safety.